CAS 3569-99-1: N-(Hydroxymethyl)nicotinamide

N-(Hydroxymethyl)nicotinamide is a nicotinamide derivative that is used for the treatment of cancer. It has been shown to inhibit carcinogenesis by binding to aminic acid and malic acid, which are metabolites of the Krebs cycle. N-(Hydroxymethyl)nicotinamide also inhibits the growth of cancer cells by binding to epidermal growth factor (EGF). Studies have shown that this drug enhances the anti-cancer effect of monoclonal antibodies. Furthermore, n-(hydroxymethyl)nicotinamide has been found to be effective in treating galleria mellonella, a type of cockroach, with x-ray crystal structures that show that it binds to acetylcholine receptors on the cell membrane.

N-(Hydroxymethyl)Nicotinamide

Applications A decomposition product found in the preparation of Nicotinic acid. References Canney, D., et al.: Bioorg. Med. Chem., 6, 43 (1998), Gozalbes, R., et al.: Antimicrob. Agents Chemother., 44, 2764 (2000), Wallace, M., et al.: Eur. J. Pharmacol., 428, 51 (2001),

N-(Hydroxymethyl)nicotinamide (Bilamid) is an antimicrobial agent.

N-(Hydroxymethyl)nicotinamide